Wyeth Raises 2007 Earnings Guidance, Buoyed By Biologics Revenues
Growth is led by 27 percent increase in revenue from biologics compared to the second quarter of 2006.
Growth is led by 27 percent increase in revenue from biologics compared to the second quarter of 2006.